#Canada #Greenway #Kingsville #Financial Statements #Cannabis Corporation

Greenway's Financial Success in Q2 2025

In a recent announcement on December 1, 2025, Greenway Greenhouse Cannabis Corporation (CSE: GWAY, OTCQB: GWAYF) revealed its financial statements for the second quarter of the fiscal year, which ended on September 30, 2025. These results demonstrate remarkable advancements in both revenue and operational efficiency for the company, a prominent cultivator of high-quality greenhouse cannabis intended for the Canadian market.

Key Financial Highlights

1. Sales Performance: The average net sales price per gram surged to $1.96 in Q2 2025, marking a 60% increase from the previous fiscal year. Concurrently, the cash cost per gram sold saw significant cost reduction, dropping to $0.72, a 28% decrease, leading to the most favorable margin between sale price and cash cost in the company's history.

2. Revenue Growth: Greenway experienced a 15% increase in net cannabis revenue, totaling $2,092,669, up from $1,806,957 in Q2 F2025. This reflects the company's effective market strategies and the growing demand for cannabis products.

3. Profitability Metrics: The gross profit for the quarter skyrocketed to $827,178, in stark contrast to a gross loss of $88,955 in the same quarter last year. This represents a substantial turnaround, demonstrating the company's commitment to enhancing operational efficiency and product quality. In the first half of fiscal 2026, gross profit accumulated to $1,641,405, boasting an unprecedented growth rate of over 500% compared to the previous year.

4. Improved Margins: Gross margins also improved significantly, reaching 40%, a marked increase from the negative 5% in the previous year. Before fair value adjustments, gross margins rose to 53% from 6%. Adjusted EBITDA was reported at $835,278, recovering from a negative EBITDA of $253,010 in Q2 F2025.

5. Operational Income: The company generated an operational income of $183,272, vastly improving from the operational loss of $770,347 reported in the same quarter a year prior.

6. Net Loss Reduction: Greenway narrowed its net loss to $114,436, representing an increase of $929,188 (89%) compared to Q2 F2025, primarily due to enhanced gross margins and improved revenue.

7. Robust Inventory: The finished goods inventory stood at 2,193,723 grams, valued at $2,626,052, ensuring the company can meet anticipated customer demands effectively.

8. Healthy Cash Flow: At the end of the quarter, Greenway had a cash balance of $1,772,884 and positive working capital amounting to $4,973,109, excluding related party amounts, supporting its operational needs and growth initiatives.

Strategic Partnerships

On July 31, 2025, Greenway entered into a significant supply agreement with 4C LABS, a UK-based leader in medical cannabis, indicating its strategy to expand into international markets. Under this agreement, Greenway will supply top-quality dried flower products to 4C LABS, which is known for handling cannabis-based pharmaceuticals in the UK. This partnership is expected to bolster Greenway's market presence and revenue streams internationally, tapping into the growing demand for medicinal cannabis.

Future Outlook

CEO Jamie D'Alimonte expressed optimism regarding the company’s growth trajectory, stating that the operational improvements have begun yielding tangible financial outcomes. He believes that with a more efficient operation and a diversified, high-value product mix, Greenway is positioned to seize new market opportunities and unlock greater long-term value for shareholders. The dedication of the team has played a pivotal role in achieving record sales margins and overall improvement in financial health.

President Carl Mastronardi echoed these sentiments, emphasizing the success of their cultivation techniques and cost management efforts, which are critical for meeting future production and sales targets. With their reinforced inventory and solid operational foundation, Greenway is prepared to navigate both Canadian and international cannabis markets successfully.

As Greenway continues to advance in the cannabis industry, the latest financial results not only underscore the company’s resilience but also its substantial potential for future growth.